Professor, Ophthalmology, Public Health and Preventive Medicine, Oregon Health and Science University
Ophthalmology
Dr. Eric B. Suhler, MD
|
|
Give Review
Eric Suhler is an expert in the field of Ophthalmology. He went to University of Texas Southwestern Medical School. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAO)". Eric Suhler is a published doctor as well. He has 74 publications published. The latest was: Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis. He is registered with Medicare.
Publications
- Risk of Retinal Neovascularization in Cases of Uveitis.
- The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis.
- Peripheral Vascular Leakage in Uveitis: Clinical and Angiographic Findings.
- Retinal detachment associated with ocular toxoplasmosis.
- Characterisation of uveitis in association with multiple sclerosis.
- Periocular Corticosteroid Injections in Uveitis: Effects and Complications.
- Rituximab Therapy for Refractory Scleritis: Results of a Phase I/II Dose-Ranging, Randomized, Clinical Trial.
- Implications of the Pacific Ocular Inflammation uveitis epidemiology study.
- Rituximab Therapy for Refractory Orbital Inflammation: Results of a Phase 1/2, Dose-Ranging, Randomized Clinical Trial.
- The course of retinal vasculitis.
- Factors Predictive of Remission of New-Onset Anterior Uveitis.
- Incidence of Visual Improvement in Uveitis Cases with Visual Impairment Caused by Macular Edema.
- The Future of Uveitis Treatment.
- Response of Pediatric Uveitis to Tumor Necrosis Factor-α Inhibitors.
- Risk of Choroidal Neovascularization among the Uveitides.
- Cytomegalovirus retinitis in the absence of AIDS.
- Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial.
- Pharmacotherapy of Scleritis: current paradigms and future directions.
- Risk factors for loss of visual acuity among patients with uveitis associated with Juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseas...
- Long-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis.
- Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study.
- Characterization of Serous retinal detachments in uveitis patients with optical coherence tomography.
- Patients with Retinal Vasculitis Rarely Suffer from Systemic Vasculitis.
- A standardized grading system for Scleritis.
- Successful treatment of refractory sympathetic ophthalmia in a child with infliximab.
- Intravenous methylprednisolone can cause an acute, vision-threatening rise in intraocular pressure.
- Cyclosporine for ocular inflammatory Diseases.
- Endogenous Streptococcus agalactiae (Group B Streptococcus) Endophthalmitis as a presenting sign of precursor T-cell lymphoblastic leukemia.
- Mycophenolate mofetil for ocular inflammation.
- Cyclophosphamide for ocular inflammatory Diseases.
- Azathioprine for ocular inflammatory Diseases.
- Management of fluocinolone implant dissociation during implant exchange.
- Infliximab therapy for refractory uveitis: 2-year results of a prospective trial.
- Uveitis in patients with autoimmune hepatitis.
- Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute Anterior uveitis cohort.
- Ocular Disease in patients with ANCA-positive vasculitis.
- Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific Northwest.
- Childhood uveitis-young patients, old problems, new perspectives.
- Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.
- A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.
- Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome.
- Toxoplasmosis retinoChoroiditis and elevated intraocular pressure: a retrospective study.
- Histopathological features of conjunctival sarcoid nodules using noninvasive in vivo conFocal microscopy.
- The role of Choroidal and retinal biopsies in the diagnosis and management of atypical presentations of uveitis.
- In vivo conFocal microscopy of keratic precipitates.
- HLA-B27-associated uveitis: overview and current perspectives.
- Mycophenolate mofetil for the treatment of Scleritis.
- Presumed teratoma-associated paraneoplastic retinopathy.
- Symmetric peripheral iris depigmentation in vogt-koyanagi-harada syndrome.
- Aqueous cell differentiation in Anterior uveitis using fourier-domain optical coherence tomography.
- Drug-induced inflammation in patients on TNFα inhibitors.
- Risk of relapse in primary acute Anterior uveitis.
- Adverse effects of smoking on patients with ocular inflammation.
- The dilemma of central serous retinopathy, a corticosteroid-induced complication, in patients with ocular inflammatory Disease.
- Hypopyon in patients with uveitis.
- Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports.
- Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study.
- Methotrexate for ocular inflammatory Diseases.
- Postmarketing surveillance rates of uveitis and Scleritis with bisphosphonates among a national veteran cohort.
- Rituximab for treatment of ocular inflammatory Disease: a series of four cases.
- Ocular inflammation in Behçet Disease: incidence of ocular complications and of loss of visual acuity.
- A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with Juvenile idiopathic arthritis.
- A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's Disease.
- Possible association between Scleritis and lymphoma.
- Methods for identifying long-term adverse effects of treatment in patients with eye Diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study.
- Biologic therapies for inflammatory eye Disease.
- How do you know?
- Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters ...
- Serpiginous Choroidopathy presenting as Choroidal neovascularisation.
- Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis.
- Prevalence of serologic evidence of cat scratch Disease in patients with neuroretinitis.
- Assessment of ophthalmology residents' contact lens training.
- Remission of Intermediate Uveitis: Incidence and Predictive Factors.
Schools
University of Texas Southwestern Medical Center At Dallas
U Hawaii
Oregon Health and Science University
National Eye InstituteNational Institutes Of Health
Conditions Treated
- Anterior Scleritis
- Behçet's Disease
- Benign Neoplasm of Choroid
- Benign Neoplasm of Eye
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAO)
Education
-
Oregon Health & Science University -
University of Hawaii -
University of Texas Southwestern Medical School
Drug Facts
| NPI NUMBER | 1275585143 | |
| NPPES Provider LastName | SUHLER | |
| NPPES Provider FirstName | ERIC | |
| NPPES Provider ZIPCode | 97239 | |
| NPPES Provider State | OR | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 91.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275585143 |
| Last Name Of The Provider | SUHLER |
| First Name Of The Provider | ERIC |
| View All |
Similar Doctors
|
|
Dr. Larry F. Rich, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald P. Davis II, MD |
|
|
Dr. Steven T. Bailey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick T. Fraunfelder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Huang, MD |
|
|
Dr. Lorinna H. Lombardi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lorri B. Wilson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justin T. Baynham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William K. Harris, MD |
|
|
Dr. Paul J. MacKenzie, MD |
|
|
Dr. Michael A. Page, MD |